Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2440]

How to fight side effects of hormone therapy for prostate cancer

How to fight side effects of hormone therapy for prostate cancer

For women with kidney cancer, belly fat matters

For women with kidney cancer, belly fat matters

Study reveals a way to make prostate cancer cells run out of energy and die

Study reveals a way to make prostate cancer cells run out of energy and die

Single-cell mRNA cytometry via sequence-specific nanoparticle clustering and trapping

Single-cell mRNA cytometry via sequence-specific nanoparticle clustering and trapping

Taking a standard prostate cancer drug with food boosts impact, lowers cost

Taking a standard prostate cancer drug with food boosts impact, lowers cost

Last Month in Oncology with Dr. Bishal Gyawali: February 2018

Last Month in Oncology with Dr. Bishal Gyawali: February 2018

Enfortumab vedotin receives FDA breakthrough designation for locally advanced or metastatic urothelial cancer

Enfortumab vedotin receives FDA breakthrough designation for locally advanced or metastatic urothelial cancer

Metabolic profiling may determine aggressiveness, prognosis of prostate cancer

Metabolic profiling may determine aggressiveness, prognosis of prostate cancer

Higher-dose RT lowers risk of recurrence but does not improve survival for men with prostate cancer

Higher-dose RT lowers risk of recurrence but does not improve survival for men with prostate cancer

Metastatic cancer cells modify bone remodeling with small RNA secretion in bone metastasis

Metastatic cancer cells modify bone remodeling with small RNA secretion in bone metastasis

More from ecancer